PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray

Clinical trial NCT05122260 · COMPLETED

Trial details

NCT number: NCT05122260
Sponsor: Kenneth Palmer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Prevention

Start date: 2021-11-11
Primary completion: 2022-01-27
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.